Becton Dickinson (BDX) Gains from Investment Securities (2009 - 2026)
Becton Dickinson (BDX) reported Gains from Investment Securities of -$98.0 million for Q1 2026, down 117.92% year-over-year from $547.0 million in Q1 2025, and down 230.67% quarter-over-quarter from $75.0 million in Q4 2025.
Becton Dickinson (BDX) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Gains from Investment Securities data on file, last reported at -$98.0 million in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at -$98.0 million, down 117.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $321.0 million (up 224.42% YoY), and the FY2025 annual result was $480.0 million, up 14.01% from the prior year.
- Gains from Investment Securities slipped to -$98.0 million in Q1 2026 per BDX's latest filing, from $75.0 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $699.0 million in Q1 2024 and troughed at -$497.0 million in Q2 2024.
- A 5-year average of $79.6 million and a median of $83.0 million in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities soared 1320.0% in 2022, then slumped 460.14% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $83.0 million in 2022, then jumped by 39.76% to $116.0 million in 2023, then tumbled by 454.31% to -$411.0 million in 2024, then jumped by 118.25% to $75.0 million in 2025, then sank by 230.67% to -$98.0 million in 2026.
- Business Quant data shows BDX's Gains from Investment Securities at -$98.0 million in Q1 2026, $75.0 million in Q4 2025, and $156.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.00 Mn |
| Mar 31, 2026 | -98.00 Mn |
| Dec 31, 2025 | 75.00 Mn |
| Dec 31, 2025 | 75.00 Mn |
| Sep 30, 2025 | 156.00 Mn |
| Sep 30, 2025 | 156.00 Mn |
| Jun 30, 2025 | 188.00 Mn |
| Jun 30, 2025 | 188.00 Mn |
| Mar 31, 2025 | 547.00 Mn |
| Mar 31, 2025 | 547.00 Mn |
| Dec 31, 2024 | -411.00 Mn |
| Dec 31, 2024 | -411.00 Mn |
| Sep 30, 2024 | 103.00 Mn |
| Sep 30, 2024 | 103.00 Mn |
| Jun 30, 2024 | -497.00 Mn |
| Jun 30, 2024 | -497.00 Mn |
| Mar 31, 2024 | 699.00 Mn |
| Mar 31, 2024 | 699.00 Mn |
| Dec 31, 2023 | 116.00 Mn |
| Dec 31, 2023 | 116.00 Mn |